Literature DB >> 20446070

A review of botulinum toxin use for chronic pelvic pain syndrome.

Henry P Gottsch1, Claire C Yang, Richard E Berger.   

Abstract

The inability of urologists to consistently and effectively treat men with chronic pelvic pain syndrome (CPPS), also known as chronic abacterial prostatitis, is a source of great frustration. Botulinum toxin (BTX), a potent neurotoxin, can act on most of the peripheral nerves of the pelvis through a variety of mechanisms. BTX injection therapy for CPPS treatment has shown modest improvements. BTX is ideal for integration into a multimodal treatment plan, which may help achieve pain relief in men with chronic pelvic pain.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20446070     DOI: 10.1007/s11934-010-0118-4

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN: 1527-2737            Impact factor:   3.092


  43 in total

1.  Sensitivity of embryonic rat dorsal root ganglia neurons to Clostridium botulinum neurotoxins.

Authors:  M J Welch; J R Purkiss; K A Foster
Journal:  Toxicon       Date:  2000-02       Impact factor: 3.033

Review 2.  Neurophysiology in neurourology.

Authors:  Margaret M Roberts
Journal:  Muscle Nerve       Date:  2008-07       Impact factor: 3.217

3.  Treatment of painful limbs/moving extremities with botulinum toxin type A injections.

Authors:  Mahmood Eisa; Carlos Singer; Cenk Sengun; Angela Russel; Bahman Jabbari; Spiridon Papapetropoulos
Journal:  Eur Neurol       Date:  2008-06-14       Impact factor: 1.710

4.  Botulinum toxin type A for chronic pain and pelvic floor spasm in women: a randomized controlled trial.

Authors:  Jason A Abbott; Sherin K Jarvis; Stephen D Lyons; Angus Thomson; Thierry G Vancaille
Journal:  Obstet Gynecol       Date:  2006-10       Impact factor: 7.661

5.  A model of neural cross-talk and irritation in the pelvis: implications for the overlap of chronic pelvic pain disorders.

Authors:  Michael A Pezzone; Ruomei Liang; Matthew O Fraser
Journal:  Gastroenterology       Date:  2005-06       Impact factor: 22.682

6.  A prospective, randomized, double-blind trial to evaluate the role of a short reducing course of oral corticosteroid therapy in the treatment of chronic prostatitis/chronic pelvic pain syndrome.

Authors:  Sylvia M Bates; Valerie A Hill; John B Anderson; Christopher R Chapple; Rosemary Spence; Claire Ryan; Martin D Talbot
Journal:  BJU Int       Date:  2007-02       Impact factor: 5.588

7.  Assessment: Botulinum neurotoxin in the treatment of autonomic disorders and pain (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.

Authors:  M Naumann; Y So; C E Argoff; M K Childers; D D Dykstra; G S Gronseth; B Jabbari; H C Kaufmann; B Schurch; S D Silberstein; D M Simpson
Journal:  Neurology       Date:  2008-05-06       Impact factor: 9.910

8.  Levofloxacin for chronic prostatitis/chronic pelvic pain syndrome in men: a randomized placebo-controlled multicenter trial.

Authors:  J Curtis Nickel; Joe Downey; Janet Clark; Richard W Casey; Peter J Pommerville; Jack Barkin; Gary Steinhoff; Gerald Brock; Allan B Patrick; Stanley Flax; Bernard Goldfarb; Bruce W Palmer; Joseph Zadra
Journal:  Urology       Date:  2003-10       Impact factor: 2.649

9.  Relief by botulinum toxin of voiding dysfunction due to benign prostatic hyperplasia: results of a randomized, placebo-controlled study.

Authors:  Giorgio Maria; Giuseppe Brisinda; Ignazio Massimo Civello; Anna Rita Bentivoglio; Gabriele Sganga; Alberto Albanese
Journal:  Urology       Date:  2003-08       Impact factor: 2.649

10.  Pelvic tenderness is not limited to the prostate in chronic prostatitis/chronic pelvic pain syndrome (CPPS) type IIIA and IIIB: comparison of men with and without CP/CPPS.

Authors:  Richard E Berger; Marcia A Ciol; Ivan Rothman; Judith A Turner
Journal:  BMC Urol       Date:  2007-10-02       Impact factor: 2.264

View more
  3 in total

Review 1.  Botulinum neurotoxin type A injection of the pelvic floor muscle in pain due to spasticity: a review of the current literature.

Authors:  Alka A Bhide; Federica Puccini; Vik Khullar; Suzy Elneil; G Alessandro Digesu
Journal:  Int Urogynecol J       Date:  2013-01-12       Impact factor: 2.894

2.  A retrospective study of the management of vulvodynia.

Authors:  Yongseok Jeon; Youngjun Kim; Bosun Shim; Hana Yoon; Youngyo Park; Bongsuk Shim; Woosik Jeong; Donghyun Lee
Journal:  Korean J Urol       Date:  2013-01-18

3.  Intraprostatic injection of botulinum toxin-A in patients with refractory chronic pelvic pain syndrome: The transurethral vs. transrectal approach.

Authors:  Mohamed A El-Enen; Mohamed Abou-Farha; Ahmed El-Abd; Hassan El-Tatawy; Ahmed Tawfik; Shawky El-Abd; Mohamed Rashed; Mahmoud El-Sharaby
Journal:  Arab J Urol       Date:  2015-02-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.